Dr. Mark Phillips, MD

NPI: 1275511966
Total Payments
$6,866
2024 Payments
$336.10
Companies
48
Transactions
452
Medicare Patients
1,317
Medicare Billing
$257,070

Payment Breakdown by Category

Food & Beverage$6,842 (99.6%)
Education$24.22 (0.4%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,842 445 99.6%
Education $24.22 7 0.4%

Top Paying Companies

Company Total Records Latest Year
PFIZER INC. $953.80 66 $0 (2024)
Collegium Pharmaceutical, Inc. $784.36 45 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $668.43 33 $0 (2024)
Daiichi Sankyo Inc. $597.45 51 $0 (2019)
Lundbeck LLC $471.13 27 $0 (2024)
Boston Scientific Corporation $454.26 24 $0 (2024)
Assertio Therapeutics, Inc. $341.84 37 $0 (2020)
RedHill Biopharma Inc. $274.28 16 $0 (2022)
Scilex Pharmaceuticals Inc. $217.10 13 $0 (2022)
Amgen Inc. $210.71 12 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $336.10 18 Collegium Pharmaceutical, Inc. ($90.16)
2023 $649.67 35 Collegium Pharmaceutical, Inc. ($190.91)
2022 $866.13 43 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($224.62)
2021 $984.81 61 RedHill Biopharma Inc. ($164.85)
2020 $445.96 26 Collegium Pharmaceutical, Inc. ($103.47)
2019 $1,129 77 ASSERTIO THERAPEUTICS, Inc. ($184.44)
2018 $1,490 110 Daiichi Sankyo Inc. ($364.48)
2017 $964.12 82 PFIZER INC. ($303.38)

All Payment Transactions

452 individual payment records from CMS Open Payments — Page 1 of 19

Date Company Product Nature Form Amount Type
12/04/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $19.00 General
Category: PAIN
09/30/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $17.10 General
Category: Opioid Analgesic
07/03/2024 Abbott Laboratories ETERNA (Device) Food and Beverage In-kind items and services $21.57 General
Category: Neuromodulation
07/02/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $20.08 General
Category: NEUROLOGY
06/20/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $24.95 General
Category: NEUROSCIENCE
06/17/2024 Boston Scientific Corporation WaveWriter Alpha Prime 16 (Device) Food and Beverage In-kind items and services $28.12 General
Category: WaveWriter Alpha_NMD
06/11/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $16.42 General
Category: Opioid Analgesic
05/21/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $18.12 General
Category: Opioid Analgesic
04/22/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $16.13 General
Category: NEUROSCIENCE
04/18/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $15.41 General
Category: PAIN
04/10/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $17.04 General
Category: NEUROLOGY
03/28/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $15.32 General
Category: Gastroenterology
03/26/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $18.12 General
Category: Opioid Analgesic
03/21/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $19.25 General
Category: NEUROSCIENCE
03/06/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $14.95 General
Category: NEUROLOGY
02/06/2024 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $16.38 General
Category: NEUROLOGY
01/18/2024 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $20.40 General
Category: Opioid Analgesic
01/09/2024 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $17.74 General
Category: NEUROSCIENCE
12/12/2023 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $13.38 General
Category: NEUROLOGY
11/27/2023 ABBVIE INC. UBRELVY (Drug), QULIPTA Food and Beverage In-kind items and services $18.43 General
Category: NEUROSCIENCE
11/16/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $16.91 General
Category: Opioid Analgesic
11/01/2023 Lundbeck LLC VYEPTI (Biological) Food and Beverage Cash or cash equivalent $19.07 General
Category: NEUROLOGY
10/26/2023 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $21.11 General
Category: PAIN
10/04/2023 Salix Pharmaceuticals, a division of Bausch Health US, LLC RELISTOR (Drug) Food and Beverage In-kind items and services $15.16 General
Category: Gastroenterology
09/18/2023 Collegium Pharmaceutical, Inc. Belbuca (Drug) Food and Beverage Cash or cash equivalent $21.75 General
Category: Opioid Analgesic

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 3 281 890 $213,340 $57,081
2022 3 314 982 $233,795 $63,983
2021 3 340 1,062 $180,550 $70,802
2020 3 382 1,229 $201,980 $65,205
Total Patients
1,317
Total Services
4,163
Medicare Billing
$257,070
Procedure Codes
12

All Medicare Procedures & Services

12 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 111 436 $135,160 $36,279 26.8%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 89 350 $73,500 $19,517 26.6%
80305 Testing for presence of drug, read by direct observation Office 2023 81 104 $4,680 $1,284 27.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 117 485 $150,350 $41,338 27.5%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 95 372 $77,910 $21,140 27.1%
80305 Testing for presence of drug, read by direct observation Office 2022 102 125 $5,535 $1,504 27.2%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 133 471 $101,265 $41,648 41.1%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 112 479 $74,245 $27,764 37.4%
80305 Testing for presence of drug, read by direct observation Office 2021 95 112 $5,040 $1,390 27.6%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 134 465 $99,975 $32,974 33.0%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 136 616 $95,480 $30,427 31.9%
80305 Testing for presence of drug Office 2020 112 148 $6,525 $1,804 27.6%

About Dr. Mark Phillips, MD

Dr. Mark Phillips, MD is a Pain Medicine healthcare provider based in Greensboro, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275511966.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Phillips, MD has received a total of $6,866 in payments from pharmaceutical and medical device companies, with $336.10 received in 2024. These payments were reported across 452 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($6,842).

As a Medicare-enrolled provider, Phillips has provided services to 1,317 Medicare beneficiaries, totaling 4,163 services with total Medicare billing of $257,070. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.

Practice Information

  • Specialty Pain Medicine
  • Location Greensboro, NC
  • Active Since 01/04/2006
  • Last Updated 03/30/2009
  • Taxonomy Code 208VP0000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1275511966

Products in Payments

  • RELISTOR (Drug) $618.58
  • LYRICA (Drug) $576.00
  • XTAMPZA (Drug) $539.17
  • VYEPTI (Biological) $471.13
  • Movantik (Drug) $467.72
  • Morphabond ER (Drug) $394.29
  • Belbuca (Drug) $212.02
  • SPECTRA WAVEWRITER (Device) $207.99
  • Nucynta (Drug) $172.86
  • Aimovig (Biological) $166.07
  • ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $139.27
  • Gralise (Drug) $136.69
  • Cambia (Drug) $130.56
  • BELBUCA (Drug) $125.84
  • NURTEC ODT (Drug) $124.70
  • RELISTOR ORAL (Drug) $107.83
  • Licart (Drug) $104.07
  • Amitiza (Drug) $86.89
  • Senza Spinal Cord Stimulation System (Device) $76.37
  • HYSINGLA ER (Drug) $68.46

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pain Medicine Doctors in Greensboro